Yasin Keshvargar
Lawyers
Filters
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
Vistra $2.25 billion secured notes offering
We advised the underwriters on the offering
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
OceanFirst Financial $225 million private placement
We are advising the placement agent on the transaction
Urban One capital raise and refinancing transaction
We advised an ad hoc group of noteholders on the transaction
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Sabre $1 billion senior secured notes issued in a pari plus structure
We advised Sabre on its high-yield notes offering and related intercompany loan
Sabre exchange offers
We are advising Sabre on the exchange offers
Immatics $125 million follow-on offering
We advised Immatics on the offering
GXO Logistics €500 million notes offering
We advised the underwriters on the debt offering